Copy For Citation
Fung S., Kwan P., Fabri M., Horban A., Pelemis M., Hann H., ...More
JOURNAL OF HEPATOLOGY, vol.66, no.1, pp.11-18, 2017 (SCI-Expanded)
-
Publication Type:
Article / Article
-
Volume:
66
Issue:
1
-
Publication Date:
2017
-
Doi Number:
10.1016/j.jhep.2016.08.008
-
Journal Name:
JOURNAL OF HEPATOLOGY
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Page Numbers:
pp.11-18
-
Keywords:
Tenofovir disoproxil fumarate, Emtricitabine, Lamivudine resistant, Viral suppression, Bone mineral density, Renal function, LONG-TERM EFFICACY, VIRUS INFECTION, COMBINATION THERAPY, ADEFOVIR, ENTECAVIR, SAFETY, MONOTHERAPY, CIRRHOSIS, LEVEL, RISK
-
Bursa Uludag University Affiliated:
Yes
Abstract
Background & Aims: Long-term treatment with tenofovir disoproxil fumarate (TDF) alone, or in combination with emtricitabine (FTC) is associated with sustained viral suppression in patients with lamivudine resistant (LAM-R) chronic hepatitis B (CHB).